clostrodium difficile

Showing 1 posts of 1 posts found.

Surprise for Seres as shares sent tumbling by Phase II failure

August 1, 2016
Research and Development, Sales and Marketing FDA, clostrodium difficile, seres therapeutics

Seres Therapeutics has presented interim results from an ongoing Phase II trial which has sent company stock spiralling downward, as …

The Gateway to Local Adoption Series

Latest content